Betaloan SUIK

Betaloan SUIK Uses, Dosage, Side Effects, Food Interaction and all others data.

Table Of contents

• Betaloan SUIK
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Betaloan SUIK
Generic	Betamethasone sodium phosphate + betamethasone acetate
Type	Injection, suspension
Therapeutic Class
Manufacturer
Available Country	United States,
Last Updated:	September 19, 2023 at 7:00 am

Uses

Short-term treatment of steroid responsive in inflammatory conditions of the eye after clinical exclusion of bacterial, viral or fungal infections. Non-infected inflammatory conditions of the ear or nose.

Dosage

Betaloan SUIK dosage

Eye: 1 or 2 drops to each affected eye every 1 or 2 hours until control is achieved, then the frequency may be reduced.Ear: 2 or 3 drops to each affected ear every 2 or 3 hours until control is achieved, then the frequency may be reduced.Nose: 2 or 3 drops instilled into each nostril 2 or 3 times daily.

Side Effects

Hypersensitivity reactions may occur leading to irritation, burning, stinging, itching and dermatitis. Topical corticosteroid use may result in corneal ulceration, increased intraocular pressure leading to optic nerve damage, reduced visual acuity. Intensive or prolonged use of topical corticosteroids may lead to formation of posterior subcapsular cataracts. In those diseases causing thinning of the cornea or sclera, corticosteroid therapy may result in thinning of the globe leading to perforation. Mydriasis, ptosis and epithelial punctate keratitis have also been reported following ophthalmic use of corticosteroids.

Precaution

Topical corticosteroids should never be given for an undiagnosed red eye. Ophthalmic treatment with corticosteroid preparations should not be repeated or prolonged without regular review to exclude raised intraocular pressure, cataract formation or unsuspected infections.

Interaction

Specific drug interaction studies have not been conducted.

Pregnancy & Breastfeeding use

There are no adequate and well controlled studies for pregnant woman. It should not be used extensively in pregnant woman. There is no information available whether it is secreted in the milk or not.

Acute Overdose

Long-term intensive topical use may lead to systemic effects.

Storage Condition

This should be protected from light, store below 25°C. Keep out of reach of children. Do not use more than 4 weeks after opening.

Innovators Monograph

You find simplified version here Betaloan SUIK